Stage 4 breast cancer is highly treatable, and many patients live active, fulfilling lives for years. While the average five-year survival rate is around 30%, individual outcomes vary greatly, and survival times are improving rapidly with newer therapies. Treatment focuses on controlling the cancer and maintaining quality of life. Key options include: Hormone therapies (like tamoxifen or letrozole) for hormone-receptor-positive cancers. Targeted therapies (such as trastuzumab or palbociclib).\n- Chemotherapy (like paclitaxel) to shrink tumours. Immunotherapy or radiation to manage specific areas.\n\nYour oncology team will customise a personalised plan tailored specifically to your cancer?s characteristics.